Evidence-based safety information about medication, vaccine, chemical and radiological exposures in pregnancy - UKTIS logo
  • Home
  • UKTIS
    • About Us
    • Meet the team
  • Resources
    • Information for healthcare providers
    • Information for pregnant women
    • UKTIS Response Statements
    • News Archive
    • Promotional material
    • Links
  • Surveillance
    • Patient confidentiality
    • Data collection
    • Reporting an exposure
    • COVID-19 Antivirals pregnancy registry
  • Research
    • Current and past projects
    • Scientific publications
  • Contact
  • Login
  • Account

UKTIS Response Statements

High-dose folic acid use in women with epilepsy in pregnancy childhood cancer risk

UKTIS OPS High dose folic acid in women with epilepsy and offspring cancer risksDownload

Librium SPC Updates Opinion Statement

Librium SPC Updates Opinion StatementDownload

Ondansetron Official Response Statement

Ondansetron UKTIS Response StatementDownload

Tocilizumab Shortage Official Position Statement

Tocilizumab Shortage Official Position StatementDownload

Help and advice

Healthcare professionals can contact UKTIS on 0344 892 0909 between 09:00-17:00 Mon-Fri (excluding bank holidays) for routine enquiries.  Urgent enquiries are answered 24 hours per day, seven days per week.

Members of the public can visit www.medicinesinpregnancy.org to access information. Or ask your GP or other health care professional to telephone UKTIS on your behalf, for up-to-date advice.

The UKTIS office (0191 213 7880) is open between 09:00-17:00 Monday-Friday (excluding bank holidays) for administration enquiries only.  No health care or pregnancy related advice is provided on this number.

Commissioned by

  • Follow us on Twitter

© UKTIS.

  • Privacy Policy
  • Cookie Policy
  • Copyright Notice
  • Terms and Conditions
  • Site Disclaimer